Ironwood Pharmaceuticals IRWD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $215.46M+143% | $88.56M-3.9% | $92.15M-86.0% | $656.2M+5.8% | ||
| $46.75M-42.9% | $81.89M-36.6% | $129.12M+11.8% | $115.46M+1.2% | ||
| $11.98M+0.5% | $11.92M-0.7% | $12.01M+55.7% | $7.72M-11.2% | ||
| $274.18M+50.3% | $182.37M-21.8% | $233.29M-70.1% | $780.63M+4.8% | ||
| $3.41M-24.2% | $4.5M-19.5% | $5.59M-11.2% | $6.29M-17.0% | ||
| $9.34M-15.3% | $11.03M-12.4% | $12.59M-10.2% | $14.02M-8.6% | ||
| $2.04M-28.7% | $2.86M-22.3% | $3.68M— | —— | ||
| $4.5M-24.0% | $5.92M+64.2% | $3.61M+326% | $847K-15.3% | ||
| $396.9M+13.1% | $350.91M-25.5% | $471.07M-57.2% | $1.1B-2.3% | ||
| $2.9M+36.2% | $2.13M-72.8% | $7.83M+1,521% | $483K-48.3% | ||
| $3.25M+2.0% | $3.19M+2.0% | $3.13M+2.0% | $3.07M-2.0% | ||
| $199.68M— | —— | $199.56M— | —— | ||
| $242.22M+524% | $38.85M-85.9% | $276.1M+982% | $25.53M-84.2% | ||
| $9.87M-19.8% | $12.3M-15.4% | $14.54M-12.4% | $16.6M-10.2% | ||
| $13.12M-15.3% | $15.49M-12.3% | $17.67M-10.1% | $19.66M-9.0% | ||
| $21.65M+26.6% | $17.11M-39.8% | $28.42M+191% | $9.77M+179% | ||
| $163K+1.9% | $160K+2.6% | $156K+1.3% | $154K-4.9% | ||
| $1.41B+1.3% | $1.4B+3.0% | $1.36B+0.5% | $1.35B-12.6% | ||
| -$1.67B+1.4% | -$1.7B+0.1% | -$1.7B-144% | -$696.38M+25.7% | ||
| -$1.06M-215% | $923K+130% | -$3.03M— | —— | ||
| -$261.84M+13.1% | -$301.34M+13.0% | -$346.3M-153% | $652.38M+7.7% | ||
| $396.9M+13.1% | $350.91M-25.5% | $471.07M-57.2% | $1.1B-2.3% | ||
| $4.5M-24.0% | $5.92M+64.2% | $3.61M+326% | $847K-15.3% | ||
| $9.34M-15.3% | $11.03M-12.4% | $12.59M-10.2% | $14.02M-8.6% | ||
| $103.43M-28.3% | $144.23M-32.1% | $212.32M-25.1% | $283.66M-14.9% | ||
| $2.04M-28.7% | $2.86M-22.3% | $3.68M— | —— | ||
| $9.34M-15.3% | $11.03M-12.4% | $12.59M-10.2% | $14.02M-8.6% | ||
| $4.5M-24.0% | $5.92M+64.2% | $3.61M+326% | $847K-15.3% | ||
| $9.34M-15.3% | $11.03M-12.4% | $12.59M-10.2% | $14.02M-8.6% | ||
| $4.5M-24.0% | $5.92M+64.2% | $3.61M+326% | $847K-15.3% | ||
| $33.24M+23.8% | $26.85M-39.3% | $44.25M+165% | $16.7M-29.1% | ||
| $3.15M-52.9% | $6.68M-68.7% | $21.33M+306% | $5.26M-66.9% | ||
| $199.68M— | —— | $199.56M— | —— | ||
| $385M0.0% | $385M+28.3% | $300M— | —— | ||
| $212.8M+1,274% | $15.49M-92.9% | $217.23M+1,005% | $19.66M-85.8% | ||
| $1.41B+1.3% | $1.4B+3.0% | $1.36B+0.5% | $1.35B-12.6% | ||
| $163K+1.9% | $160K+2.6% | $156K+1.3% | $154K-4.9% | ||
| $385M0.0% | $385M+28.3% | $300M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ironwood Pharmaceuticals's total assets?
- Ironwood Pharmaceuticals (IRWD) holds $434.6M in total assets, up 32.8% year over year.
- How much debt does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals carries $212.4M in total debt against -$217.1M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals holds $220.5M in cash and equivalents.
- Can Ironwood Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.41 — current assets exceed current liabilities.
- Where does Ironwood Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
